cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma

BMC Genomics

Volumn 5, Issue , 2004, Pages

  Chan, Qing Rong ^a   Bilke, Sven ^a   Wei, Jun S ^a   Whiteford, Craig C ^a   Cenacchi, Nicola ^a   Krasnoselsky, Alexei L ^a   Greer, Braden T ^a   Son, Chang Gue ^a,b   Westermann, Frank ^c   Berthold, Frank ^d   Schwab, Manfred ^c   Catchpoole, Daniel ^e   Khan, Javed ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Daejeon University   (South Korea)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; MYC PROTEIN; NAG PROTEIN; NCYM PROTEIN; UNCLASSIFIED DRUG;

AMPLICON; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CHROMOSOME 12Q; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 2P; CHROMOSOME 3P; CHROMOSOME 7Q; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; EXPRESSED SEQUENCE TAG; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INFANT; MALE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NEUROBLASTOMA; PHENOTYPE; PRESCHOOL CHILD; PROBABILITY;

EID: 9144245019     PISSN: 14712164     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2164-5-70     Document Type: Article

References (41)

1. Brodeur GM: Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003, 3:203-16.
2. Brodeur GM, Azar C, Brother M, Hiemstra J, Kaufman B, Marshall H, Moley J, Nakagawara A, Saylors R, Scavarda N, et al.: Neuroblastoma. Effect of genetic factors on prognosis and treatment Cancer 1992, 70:1685-94.
3. Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Boecker W, Lampert F, Stoerkel S: Comparative genomic hybridization (CGH) analysis of neuroblastomas - an important methodological approach in paediatric tumour pathology. J Pathol 1997, 181:394-400.
4. Plantaz D, Vandesompele J, Van Roy N, Lastowska M, Bown N, Combaret V, Favrot MC, Delattre O, Michon J, Benard J, et al.: Comparative genomichybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer 2001, 91:680-6.
5. Cohen N, Betts DR, Trakhtenbrot L, Niggli FK, Amariglio N, Brok-Simoni F, Rechavi G, Meitar D: Detection of unidentified chromosome abnormalities in human neuroblastoma by spectral karyotyping (SKY). Genes Chromosomes Cancer 2001, 31:201-8.
6. Schleiermacher G, Janoueix-Lerosey I, Combaret V, Derre J, Couturier J, Aurias A, Delattre O: Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma Cancer Genet Cytogenet 2003, 141:32-42.
7. Schwab M, Varmus HE, Bishop JM: Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture Nature 1985, 316:160-2.
8. Maris JM, Matthay KK: Molecular biology of neuroblastoma J Clin Oncol 1999, 17:2264-79.
9. Vandesompele J, Speleman F, Van Roy N, Laureys G, Brinskchmidt C, Christiansen H, Lampert F, Lastowska M, Bown N, Pearson A, et al.: Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there? Med Pediatr Oncol 2001, 36:5-10.
10. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, et al.: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998, 20:207-11.
11. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, et al.: Assembly of microarrays for genome-wide measurement of DNA copy number Nat Genet 2001, 29:263-4.
12. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO: Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999, 23:41-6.
13. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL, Brown PO: Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 2002, 99:12963-8.
14. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringner M, Sauter G, Monni O, Elkahloun A, et al.: Impact of DNA amplification on gene expression patterns in breast cancer Cancer Res 2002, 62:6240-5.
15. Heiskanen MA, Bittner ML, Chen Y, Khan J, Adler KE, Trent JM, Meltzer PS: Detection of gene amplification by genomic hybridization to cDNA microarrays. Cancer Res 2000, 60:799-802.
16. Beheshti B, Braude I, Marrano P, Thorner P, Zielenska M, Squire JA: Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Neoplasia 2003, 5:53-62.
17. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, et al.: Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001, 7 673-9.
18. Khan J, Saal LH, Bittner ML, Jiang Y, Gooden GC, Glatfelter AA, Meltzer PS: Gene expression profiling in cancer using cDNA microarrays. Methods Mol Med 2002, 68:205-22.
19. Chen Y, Dougherty ER, Bittner ML: Ratio-based decisions and the quantitative analysis of cDNA microarray images. Biomedical Optics 1997, 2:364-374.
20. De Preter K, Speleman F, Combaret V, Lunec J, Laureys G, Eussen BH, Francotte N, Board J, Pearson AD, De Paepe A, et al.: Quantification of MYCN, DDXI, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod Pathol 2002, 15 159-66.
21. Tonin PN, Yeger H, Stallings RL, Srinivasan PR, Lewis WH: Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines. Oncogene 1989, 4:1117-21.
22. Kuroda H, White PS, Sulman EP, Manohar CF, Reiter JL, Cohn SL, Brodeur GM: Physical mapping of the DDXI gene to 340 kb 5′ of MYCN. Oncogene 1996, 13:1561-5.
23. Jones TA, Flomen RH, Senger G, Nizetic D, Sheer D: The homeobox gene MEISI is amplified in IMR-32 and highly expressed in other neuroblastoma cell lines. Eur J Cancer 2000, 36:2368-74.
24. Armstrong BC, Krystal GW: Isolation and characterization of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-myc. Cell Growth Differ 1992, 3:385-90.
25. Wimmer K, Zhu XX, Lamb BJ, Kuick R, Ambros PF, Kovar H, Thoraval D, Motyka S, Alberts JR, Hanash SM: Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma. Oncogene 1999, 18:233-8.
26. Miyake I, Hakomori Y, Shinohara A, Gamou T, Saito M, Iwamatsu A, Sakai R: Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines. Oncogene 2002, 21:5823-34.
27. De Preter K, Pattyn F, Berx G, Strumane K, Menten B, Van Roy F, De Paepe A, Speleman F, Vandesompele J: Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons. BMC Genomics 2004, 5 11.
28. Corvi R, Savelyeva L, Breit S, Wenzel A, Handgretinger R, Barak J, Oren M, Amler L, Schwab M: Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma. Oncogene 1995, 10:1081-6.
29. Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R: Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene 1995, 10:291-7.
30. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, et al.: A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A 1995, 92 5520-4.
31. Morowitz M, Shusterman S, Mosse Y, Hii G, Winter CL, Khazi D, Wang Q, King R, Maris JM: Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction. Mod Pathol 2003, 16:1248-56.
32. Tonini GP, Romani M: Genetic and epigenetic alterations in neuroblastoma. Cancer Lett 2003, 197:69-73.
33. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B: Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001, 61:6649-55.
34. Munnia A, Schutz N, Romeike BF, Maldener E, Glass B, Maas R, Nastainczyk W, Feiden W, Fischer U, Meese E: Expression, cellular distribution and protein binding of the glioma amplified sequence (GAS41), a highly conserved putative transcription factor. Oncogene 2001, 20:4853-63.
35. Saito-Ohara F, Imoto I, Inoue J, Hosoi H, Nakagawara A, Sugimoto T, Inazawa J: PPMID is a potential target for 17q gain in neuroblastoma. Cancer Res 2003, 63:1876-83.
36. Sokal A: Monte Carlo methods in statistical mechanics: foundations and new algorithms. In: Funtial Integration: Basics and Applicaitons Edited by: CP DeWitt-Morette C, Folacci A Cargese. France: Proceedings of the NATO ASI B-361; 1996.
37. Ejeskar K, Aburatani H, Abrahamsson J, Kogner P, Martinsson T: Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene. Br J Cancer 1998, 77:1787-91.
38. Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, et al.: Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 1999, 18:4948-57.
39. Luttikhuis ME, Powell JE, Rees SA, Genus T, Chughtai S, Ramani P, Mann JR, McConville CM: Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis. Br J Cancer 2001, 85 531-7.
40. Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE, Brodeur GM: Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci U S A 1989, 86:3753-7.
41. Hackett CS, Hodgson JG, Law ME, Fridlyand J, Osoegawa K, De Jong PJ, Nowak NJ, Pinkel D, Albertson DG, Jain A, et al.: Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors. Cancer Res 2003, 63:5266-5273.